[ACCESSWIRE]
LOS ANGELES, CA / ACCESSWIRE / November 21, 2017 / Pediapharm Inc. (TSX-V: PDP), Canada's Leading Pediatric Pharmaceutical Company, announced today that it will be presenting at the 10th annual LD Micro Main Event on Thursday, December 7, at 9:30AM PST / 12:30PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Sylvain Chretien, CEO of Pediapharm Inc, will be presenting, as well as meeting with investors.
The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinate evening events.
News Compliments of ACCESSWIRE.
About Pediapharm Inc.
Pediapharm is the only Canadian specialty pharmaceutical company dedicated to serving the needs of the pediatric community. Its mission is to bring to the Canadian market the latest innovative pediatric products with the objective to improve the health and the well-being of children in Canada. Since its debut in 2008, Pediapharm has entered into numerous commercial agreements with partners from Canada and other countries around the world. The Company's innovative product portfolio includes NYDA®, a breakthrough treatment for head lice; EpiCeram®, a non-steroid emulsion for eczema; naproxen suspension, indicated to treat pain and inflammation due to various conditions, including Juvenile Idiopathic Arthritis; Rupall™, an innovative new allergy medication with a unique mode of action; Otixal®, the first and only antibiotic and steroid combination ear drop available in single, sterile, preservative-free and unit-dose packaging; and Cuvposa™, for chronic severe drooling, a condition affecting a significant proportion of cerebral palsy patients.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually.
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com/events for more information.
Contact:
Name: Roland Boivin, CFO
Phone: 514-762-2626 ext 202
Address: 225 - 1 Place du Commerce, Verdun, QC, Canada, H3E 1A2
Email: [email protected]
SOURCE: Pediapharm Inc.
